A retrospective, non-interventional real-world outcomes of first-line therapy of Sorafenib in advanced hepatocellular carcinoma
Latest Information Update: 22 May 2019
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 22 May 2019 Results presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 19 Feb 2019 New trial record
- 19 Jan 2019 Real world results for first line therapy of Sorafenib in advanced hepatocellular carcinoma were presented at the 2019 Gastrointestinal Cancers Symposium.